CMCAssist ApS
Private limited companyCVR 37850861FrederiksbergActive
CMCAssist ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2016. Net profit fell 17% from 2024 to 2025, ending at DKK 180k. Equity grew to DKK 898k in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 18% (2024 → 2025), to DKK 2.4m.
- Net profit fell 17% (2024 → 2025), to DKK 180k.
- Equity rose 25% (2024 → 2025), to DKK 898k.
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 2,245 | 2,815 | 2,026 | 3,059 | 2,952 | 2,419 | −18.1% |
| Operating profit (EBIT) | 307 | 826 | −571 | 655 | 356 | 275 | −22.9% |
| Profit before tax | 296 | 794 | −618 | 590 | 285 | 232 | −18.6% |
| Net profit | 241 | 622 | −485 | 458 | 216 | 180 | −16.7% |
| Total assets | 2,097 | 2,916 | 1,732 | 1,855 | 2,229 | 2,539 | +13.9% |
| Equity | 777 | 1,122 | 45 | 503 | 719 | 898 | +25% |
| Liabilities | 1,206 | 1,661 | 1,687 | 1,237 | 1,414 | 1,563 | +10.6% |
| Cash and cash equivalents | 483 | 1,061 | 461 | 178 | 1,238 | 1,103 | −10.9% |
| Average number of employees | 3 | 3 | 4 | 3 | 4 | 3 | −25% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 06/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 13/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 28/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 04/07/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 26/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 16/07/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 26,984of 69,742 Better than 61% | No. 35,062of 69,964 Better than 50% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 79of 323 Better than 76% | No. 157of 329 Better than 52% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 15,104of 33,588 Better than 55% | No. 16,168of 33,687 Better than 52% |
| All companies of type ApS66,508 companies in the comparison | No. 26,356of 66,379 Better than 60% | No. 30,909of 66,505 Better than 54% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- CMCAssist ApSDKK 2.4m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- CMCAssist ApSDKK 180k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- CMCAssist ApSDKK 898k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- CMCAssist ApS4
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- CMCHoldings ApS100%
Management
1 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Jens Thostrup Bukrinski | CEO | 04/07/2016 |
- Founders
- CMCHoldings ApS
Signing rule: Selskabet tegnes af en direktør alene, eller af hele direktionen i forening.
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| CMCAssist ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 4 | 1021568224 |
Purpose
Selskabets formål er at levere konsulent- og serviceydelser relaterede til udvikling og fremstilling af biofarmaceutiske produkter, karakterisering, pre-formulering og formulering af lægemidler, proces- og analytisk udvikling, produktions-opskalering og cGMP-fremstilling af biologisk aktive farmaceutiske ingredienser til prækliniske og kliniske forsøg, muligheds- og risikoanalyse og at udføre aktiviteter, der er forbundet hermed.
The purpose is quoted from the register in Danish.
Changes year by year
13 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changesaddress 1 · accounts 1
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20222 changesname 1 · accounts 1
- NameName changed from CMCassist ApS to CMCAssist ApS
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20201 changeaddress 1
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
20163 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as CMCassist ApS
- ManagementJens Thostrup Bukrinski appointed ceo
- OwnershipCMCHoldings ApS registered as owner (100%)
Related companies
Same industry in Frederiksberg
- Adcendo ApS49 employees
- Orbis Medicines ApS32 employees
- Minervax ApS28 employees
- Inprother ApS18 employees
- Acesion Pharma ApS16 employees
- Kost Studio ApS11 employees
Same people in management
- Epoqe Pharma ApSvia Jens Thostrup Bukrinski
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.